VERTEX PHARMACEUTICALS INC / MA Total Operating Expenses 2008-2026 | VRTX
What is total operating expenses?
Total operating expenses include all costs related to running the core business, including cost of goods sold, R&D, and SG&A.
What is VERTEX PHARMACEUTICALS INC / MA's current total operating expenses?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual total operating expenses for 2025 was $7.83B, a 30.44% decline from 2024. VERTEX PHARMACEUTICALS INC / MA total operating expenses for the quarter ending March 31, 2026 was $1.85B.
What was VERTEX PHARMACEUTICALS INC / MA's total operating expenses in 2024?
VERTEX PHARMACEUTICALS INC / MA annual total operating expenses for 2024 was $11.25B, a 86.39% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's total operating expenses in 2023?
VERTEX PHARMACEUTICALS INC / MA annual total operating expenses for 2023 was $6.04B, a 30.58% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year total operating expenses CAGR?
VERTEX PHARMACEUTICALS INC / MA total operating expenses grew at a compound annual growth rate (CAGR) of 18.51% from FY2020 to FY2025, going from $3.35B to $7.83B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.83B | -30.4% | 10-K |
| FY2024 | $11.25B | +86.4% | 10-K |
| FY2023 | $6.04B | +30.6% | 10-K |
| FY2022 | $4.62B | -3.5% | 10-K |
| FY2021 | $4.79B | +43.1% | 10-K |
| FY2020 | $3.35B | +13.0% | 10-K |
| FY2019 | $2.97B | +22.9% | 10-K |
| FY2018 | $2.41B | +2.0% | 10-K |
| FY2017 | $2.37B | +39.8% | 10-K |
| FY2016 | $1.69B | +12.9% | 10-K |
| FY2015 | $1.50B | +17.8% | 10-K |
| FY2014 | $1.27B | -30.1% | 10-K |
| FY2013 | $1.82B | +23.1% | 10-K |
| FY2012 | $1.48B | +14.2% | 10-K |
| FY2011 | $1.30B | +54.5% | 10-K |
| FY2010 | $839.4M | +17.3% | 10-K |
| FY2009 | $715.9M | +12.2% | 10-K |
| FY2008 | $638.2M | - | 10-K |